Delivery Order SPE2DB24D1104-SPE2DB24FYCU7

Award Date 9/12/24
Potential Completion Date 9/13/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $14,336.14. The contract has a firm fixed price pricing type and an ultimate completion date of September 19, 2024. This order is a component of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $16,678.56 and a performance period through September 18, 2024. This is a delivery order contract with a firm-fixed price pricing type. The award is not associated with a set-aside designation. AmerisourceBergen holds...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of 4,565,391,887 units of the pharmaceutical product MULTAQ 400 MG TABLET 60S. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a ceiling value of $7,928.73 and a completion date of August 9, 2024. This appears to be a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at up to $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide MULTAQ 400 MG TABLET 60S. The award has a ceiling value of $29,635.33 and an ultimate completion date of September 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows DLA Troop Support Medical to efficiently procure a comprehensive range of medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $6,474.84 and a performance period ending on February 7, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product MULTAQ 400 MG TABLET 60S. The contract has a ceiling value of $2,995.28 and is a firm fixed-price contract. It has an ultimate completion date of October 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MULTAQ 400 MG TABLET 60S. The contract has a completion date of February 29, 2024 and a potential value of $3,038.55. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $12,034.92 and is a firm fixed-price contract type, with an ultimate completion date of February 4, 2025. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of MULTAQ 400 MG TABLET 60S. The delivery order, valued at $1,937.34, is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and runs through December 2025. This contract vehicle allows the DLA to efficiently procure a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,119.52, is for the delivery of MULTAQ 400 MG TABLET 60S, a medical product. The contract is a firm fixed-price delivery order with a completion date of January 16, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA,...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB24FYCU7
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corporation for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $11,359.85 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs and other critical care materials, from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion on September 13, 2024.

Generated 12/12/24, 9:23 AM